Prothena Corp. plc Stock
Prothena Corp. plc Stock
Prothena Corp. plc shows a slight decrease today, losing -€0.200 (-1.000%) compared to yesterday.
Prothena Corp. plc is currently one of the favorites of our community with 13 Buy predictions and no Sell predictions.
Based on the current price of 20.0 € the target price of 80 € shows a potential of 300.0% for Prothena Corp. plc which would more than double the current price.
Pros and Cons of Prothena Corp. plc in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
S********** s********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prothena Corp. plc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Prothena Corp. plc | -1.000% | -7.407% | 3.627% | -69.697% | -42.529% | 1.010% | - |
Ardelyx Inc. | -10.570% | -13.495% | 3.392% | 89.573% | 7.578% | 9.088% | - |
Evolus Inc | -5.830% | -8.130% | 6.604% | 32.164% | 24.862% | 51.678% | - |
Salarius Pharmaceuticals Inc. | 5.580% | 0.971% | -2.804% | -69.412% | -25.045% | -98.384% | -99.993% |
Comments
Prothena Co. plc (NASDAQ: PRTA) had its price target lowered by analysts at HC Wainwright from $90.00 to $84.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Show more
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
Show more
Ratings data for PRTA provided by MarketBeat